Search Results
Jun 08, 2026, 10:01 ET Pneumonia Market Set to Witness Robust Growth During the Forecast Period (2026-2036), Driven by Advancing Therapeutics and Rising Disease Burden | DelveInsight
community-acquired pneumonia (CAP) is estimated at approximately 24.8 cases per 10,000 adults, with rates increasing significantly with advancing age.Leading pneumonia companies, such as Aridis Pharmaceuticals, Aptarion Biotech, Biotest AG, Vaxcyte, Inc., CanSinoBIO, Inventprise, BioVersys,
More news about: DelveInsight Business Research, LLP
Jun 08, 2026, 09:00 ET BetaNXT CEO Robert Santella Named FinTech Business Leader of the Year at the 2026 FTF News Technology Innovation Awards
BetaNXT's solutions streamline operations, enhance productivity, strengthen compliance and reduce enterprise cost, helping clients excel in the digital age. For more information, visit
More news about: BetaNXT
Jun 08, 2026, 09:00 ET Contractor Training Center Expands into Massachusetts, Supporting Workforce Development Through Electrical Licensing Education
Group, which is building the future of professional education by empowering professionals to achieve more, adapt, and thrive in their careers. In the age of AI, Colibri helps more than 3 million professionals annually across essential industries, including real estate, construction, and financial services,
More news about: Contractor Training Center
Jun 08, 2026, 08:34 ET InfoHawk Raises $2.25M in Pre-Seed Funding to Detect and Prevent AI-Driven Deception and Scams
Poiesz, and Jamie McCrindle. Fraud and scams have grown from an internet nuisance into one of the defining threats of the digital age. If scams were a country, it would rank around 30th in the world by GDP — bigger than Austria, Colombia, or Singapore. Consumers globally lost an estimated
More news about: InfoHawk
Jun 08, 2026, 08:30 ET Kye Pharmaceuticals Announces the Availability of Dyanavel® XR Tablets Across Canada for the Treatment of ADHD
extended-release) - tablets and oral suspension are authorized for use in Canada for the treatment of ADHD in children 6 to 12 years of age as well as in adults 18 years of age and over. The onset of action is significant at 60 minutes post dose with a duration of therapy of 13 hours.1 Dyanavel®
More news about: Kye Pharmaceuticals Inc.
Jun 08, 2026, 08:30 ET Neurocrine Biosciences Presents New Data Highlighting Functional and Socio-emotional Improvements with INGREZZA® (valbenazine) Capsules in Individuals with Tardive Dyskinesia and Intellectual and Developmental Disabilities
treatment and had at least one follow‑up visit, including a subgroup of 30 individuals with reported intellectual and developmental disabilities (mean age: 47.3 years; standard deviation: 14.6). The most common psychiatric comorbidities in this subgroup were schizophrenia (70%) and mood disorders (17%).
More news about: Neurocrine Biosciences, Inc.
Jun 08, 2026, 08:08 ET Neem Medical Spa Expands to Chestnut Hill, Bringing Physician-Led Aesthetic, Longevity, and Wellness Care to Greater Boston
help patients look refreshed, feel confident, and age strategically-not reactively."I founded Neem Medical Spa because I wanted to move beyond simply treating symptoms of aging and help people proactively optimize how they look, feel, and age," said Dr. Rosy Sandhu, Founder and Medical Director
More news about: Neem Medical Spa
Jun 08, 2026, 08:05 ET THERABODY LAUNCHES CRYOTHERM™ PALM, ITS FIRST THERMOREGULATION PERFORMANCE DEVICE, BRINGING SCIENCE-BACKED PALM COOLING TO MANAGE HEAT ON SPORT'S BIGGEST STAGE
application between sets. Results compare intervention to control conditions and may not reflect outcomes in other training contexts, athlete levels, age groups, or populations. Full study details at therabody.com/science.
More news about: Therabody
Jun 08, 2026, 08:05 ET THERABODY LAUNCHES CRYOTHERM™ PALM, ITS FIRST THERMOREGULATION PERFORMANCE DEVICE, BRINGING SCIENCE-BACKED PALM COOLING TO MANAGE HEAT ON SPORT'S BIGGEST STAGE
application between sets. Results compare intervention to control conditions and may not reflect outcomes in other training contexts, athlete levels, age groups, or populations. Full study details at therabody.com/science.
More news about: Therabody
Jun 08, 2026, 08:00 ET Kayne Anderson Real Estate Announces Recapitalization of Class A Senior Housing Portfolio in Partnership with Tradition Senior Living
independent living units, 348 assisted living units and 151 memory care units, providing residents with a full continuum of care and the ability to age in place within their local communities. The Portfolio is approximately 96% occupied and is recognized for its premium amenities, extensive programming
More news about: Kayne Anderson Real Estate
Jun 08, 2026, 08:00 ET Vasa Therapeutics to Deliver Two Presentations on VS-041 at ECM2026, Featuring Preclinical and First-in-Human Data and Ongoing Phase 1c Trial Design in HFpEF
Vasa Therapeutics is a clinical-stage biopharmaceutical company committed to delivering first-inclass innovations for cardiovascular, neuromuscular and age-related disorders. By focusing on mechanisms with strong clinical relevance, Vasa aims to deliver disease-modifying therapies that drive real patient
More news about: Vasa Therapeutics
Jun 08, 2026, 08:00 ET Apnimed Appoints Experienced Pharmaceutical Executive Kevin R. Lind as Chief Executive Officer to Implement Next Phase of Growth Strategy
dysfunction during sleep and predisposing anatomic abnormalities. OSA affects individuals across all walks of life, impacting both males and females of all age groups, ethnicities, and weight classes, including those with or without obesity. An estimated 80 million people in the United States and one billion
More news about: Apnimed, Inc.
Jun 08, 2026, 08:00 ET AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026
those with progression of disease less than or equal to two years from the date of initial frontline therapy (POD24).1Across the age subgroups, ORR and complete response rates (CRR) for E+R2 and R2 for ≥65 were (94.3% vs 80.2% and 80.7% vs 44.3%, respectively)
More news about: AbbVie
Jun 08, 2026, 08:00 ET AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026
those with progression of disease less than or equal to two years from the date of initial frontline therapy (POD24).1Across the age subgroups, ORR and complete response rates (CRR) for E+R2 and R2 for ≥65 were (94.3% vs 80.2% and 80.7% vs 44.3%, respectively)
More news about: AbbVie
Jun 08, 2026, 07:30 ET ENHANCED GAMES SUCCESS DRIVING SIGNIFICANT GROWTH FOR "LIVE ENHANCED" CONSUMER PLATFORM
AdvertisingThe defining stories of the inaugural Enhanced Games were the extraordinary personal-best performances delivered by athletes. At an average age of 30, competing athletes achieved 21 personal bests, with many surpassing marks they had set a decade or more earlier.For example,
More news about: Enhanced
Jun 08, 2026, 00:41 ET A New Lease of Life: Stories of Hope, Survivorship and Second Chances with Apollo Hospitals
and history of cardiac bypass surgery, he was diagnosed with an aggressive bladder cancer. The diagnosis was particularly concerning because of his age, underlying health conditions and the complexity of the tumour. Using the advanced da Vinci Xi robotic surgical system, a team led by Dr Harshit Garg,
More news about: Apollo Hospitals
Jun 07, 2026, 16:45 ET Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
cardiovascular events in patients with high-risk diabetes. Of the overall study population of 12,257 patients, 6,002 (49%) had high-risk diabetes, with a median age of 66 and 50% female. Evolocumab lowered LDL-C by more than 50%, down to 45 mg/dL. After a median follow-up of 4.6 years, there was a 29% reduction in
More news about: American Diabetes Association
Jun 07, 2026, 16:45 ET AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
Updated March 1, 2024. Accessed May 14, 2026.Fryar CD, Afful J, Saif NT. Prevalence of overweight, obesity, and severe obesity among adults age 20 and over: United States, 1960–1962 through August 2021-August 2023. NCHS Health E-Stat. 2026 Feb;(111):1–7.NCD Risk Factor Collaboration
More news about: Amgen
Jun 07, 2026, 10:30 ET MimiSilk marque 12 ans de soins avancés avec le lancement de nouveaux produits et une vente anniversaire
autonome efficace et comme un complément à long terme aux traitements RF cliniques, Vera représente l'avancée continue de MimiSilk dans la technologie anti-âge accessible.Parallèlement à Vera, MimiSilk présente le masque de visage au collagène
More news about: MimiSilk
Jun 07, 2026, 08:00 ET Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk unveils new data at ADA 2026
stroke) in people under 18 yearsto help children under 12 years of age lose weight and keep the weight offIt is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age.Important Safety InformationWhat is the most important
More news about: NOVO NORDISK INC.
Jun 07, 2026, 06:00 ET Vision Insurance After Retirement (2026): VSP Vision Care Named Leading Option for Retiree Eye Coverage by Expert Consumers
care. According to Expert Consumers, demand for individual vision insurance plans for retirees continues to rise, driven by increasing awareness of age-related eye conditions and the need for predictable healthcare costs.What Is Vision Insurance After Retirement?Vision insurance
More news about: ExpertConsumers.org
Jun 06, 2026, 14:45 ET 82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with Continuous Glucose Monitoring
trial was a multicenter study conducted across 22 primary care practices in the U.S. and included 283 adults with type 2 diabetes not on insulin (mean age 60; 32% racial or ethnic minority participants; A1C 7.1% to 14.9%). The trial evaluated the impact of CGM on blood glucose management and A1C levels
More news about: American Diabetes Association
Jun 06, 2026, 11:00 ET Clinical Amino Acid Profiles Anchor PureHealth Research's New Natural Peptides Supplements
particular, help support the structural framework of the skin, joints, tendons, and connective tissues – the areas that tend to change naturally with age.To support those processes, PureHealth Research formulates its natural peptide supplements with premium Morikol® Tripeptides, an advanced
More news about: PureHealth Research LLC
Jun 06, 2026, 09:00 ET New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis
shared at the American Diabetes Association's (ADA) June 2026 86th Scientific Sessions show sharp increases in DKA-related hospitalizations across all age groups nationwide. The data reinforces that while diabetes technology has advanced significantly, there are opportunities to better detect rising ketones
More news about: Abbott
Jun 06, 2026, 07:51 ET Chandigarh University holds 8th CU Online Annual Convocation; 363 Students Degrees Awarded
personal circumstances."The convocation reflected the inclusive nature of online education, bringing together learners from diverse backgrounds and age groups. The graduating cohort included a 63-year-old retired professional who earned an MSc in Data Science, homemakers balancing family responsibilities
More news about: Chandigarh University